These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2802259)

  • 21. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral administration of nifedipine on neuropeptide Y- and noradrenaline-induced vasoconstriction in the human forearm.
    Pernow J; Lundberg JM; Kaijser L
    Clin Physiol; 1989 Feb; 9(1):67-75. PubMed ID: 2706916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of nisoldipine on large coronary arteries in situ: inhibition of vasoconstriction induced by vasopressin.
    Saito T; Saeed M; Bing RJ
    Pharmacology; 1988; 37(2):85-93. PubMed ID: 3212040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference of angiotensin-converting enzyme inhibition with vasoactive peptides in the coronary circulation of dogs.
    Bauer B; Neubauer S; Spindler M; Dürr R; Becker HH; Ertl G
    J Cardiovasc Pharmacol; 1995 May; 25(5):756-62. PubMed ID: 7630154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of nifedipine and nisoldipine on coronary vasoconstriction in the Langendorff-perfused rat heart.
    Okada T; Izawa N; Nakamura T
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):145-9. PubMed ID: 10630745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin.
    Winniford MD; Jansen DE; Reynolds GA; Apprill P; Black WH; Hillis LD
    Am J Cardiol; 1987 Feb; 59(4):203-7. PubMed ID: 3101478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
    Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-related effects of intracoronary application of nisoldipine on central and peripheral circulatory parameters.
    Schartl M; Heidelmeyer C; Veit S; Dougherty C; Brückner JB
    Arzneimittelforschung; 1989 Jun; 39(6):682-5. PubMed ID: 2775335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
    Martin SE; Tidmore WC; Patterson RE
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
    el Din MM; Malik KU
    J Pharmacol Exp Ther; 1988 Aug; 246(2):479-84. PubMed ID: 3404443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary vascular responsiveness to non-eicosanoid vasoconstrictors in the perfused diabetic rat heart.
    Roth DM; Foster KA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):317-20. PubMed ID: 6207576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium inhibits the responses to neuropeptide Y in the rabbit coronary artery.
    Corr L; Burnstock G; Poole-Wilson P
    J Mol Cell Cardiol; 1991 Mar; 23(3):231-5. PubMed ID: 1880809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of neurotensin and neuropeptide Y on coronary circulation and myocardial function in dogs.
    Ertl G; Bauer B; Becker HH; Rose G
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1062-8. PubMed ID: 8476083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
    Gross GJ; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of endothelin on the coronary vascular bed in open-chest dogs.
    Clozel JP; Clozel M
    Circ Res; 1989 Nov; 65(5):1193-200. PubMed ID: 2680149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling mechanisms for muscarinic receptor-mediated coronary vasoconstriction in isolated rat hearts.
    Zhang Y; Hoover DB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):96-106. PubMed ID: 10734158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of neuropeptide Y on cochlear blood flow in guinea pigs.
    Itou M; Ogawa K; Inoue Y; Sato M; Kanzaki J
    Acta Otolaryngol; 2001 Jul; 121(5):573-8. PubMed ID: 11583388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart.
    Komaru T; Ashikawa K; Kanatsuka H; Sekiguchi N; Suzuki T; Takishima T
    Circ Res; 1990 Nov; 67(5):1142-51. PubMed ID: 2225353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.